Lords Science Committee to take evidence on the manufacture of regenerative treatments

14 December 2012


The House of Lords Science Committee will next week take evidence from witnesses expert in manufacturing cell therapies and other regenerative treatments. The Committee will quiz the witnesses on how, for example, small scale cell therapy research can be scaled-up to treat large numbers of patients.

The Committee will ask the witnesses what infrastructure needs to be developed to deliver regenerative treatments in the UK, and about the role of the public and private sector in these efforts. It will also discuss the role of the new Cell Therapy Catapult with its Chief Executive.

The evidence sessions will start at 10:40am on Tuesday 18 December in Committee Room 4 of the House of Lords. The witness details are:

At 10:40am:   

  • Dr David Newble, Chief Executive Officer, TAP Biosystems;
  • Keith Thompson, Chief Executive Officer, Cell Therapy Catapult Centre; and
  • Prof David Williams, Director EPSRC Centre for Innovative Manufacturing in Regenerative Medicine, Loughborough University.

At 11:40am:   

  • Dr Zahid Latif, Head of Healthcare, Technology Strategy Board; and
  • Keith Thompson, Chief Executive Officer, Cell Therapy Catapult Centre.

The evidence sessions will be webcast live at www.parliamentlive.tv.

The evidence sessions are also open to the public. Journalists wishing to attend should go to Parliament’s Cromwell Green Entrance and should allow time for security screening.

Subscribe to Lords newsletter

Sign up for the House of Lords newsletter for the latest news, debates and business